Alerts will be sent to your verified email
Verify Email
BALGOPAL
|
Balgopal Commercial
|
Sicagen India
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.64 % | 1.1 % | 29.33 % |
|
5yr average Equity Multiplier
|
1.19 | 1.55 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.37 | 1.15 | 1.5 |
|
5yr Avg Net Profit Margin
|
38.48 % | 0.54 % | 11.83 % |
|
Price to Book
|
5.19 | 0.6 | 1.19 |
|
P/E
|
46.47 | 17.07 | 11.02 |
|
5yr Avg Cash Conversion Cycle
|
-18.38 Days | 125.97 Days | 133.11 Days |
|
Inventory Days
|
199.86 Days | 60.81 Days | 68.7 Days |
|
Days Receivable
|
0.0 | 100.11 Days | 81.67 Days |
|
Days Payable
|
94.38 Days | 49.14 Days | 60.92 Days |
|
5yr Average Interest Coverage Ratio
|
165.08 | 2.05 | 92.41 |
|
5yr Avg ROCE
|
19.36 % | 3.9 % | 40.34 % |
|
5yr Avg Operating Profit Margin
|
-16.66 % | 2.44 % | 18.05 % |
|
5 yr average Debt to Equity
|
0.0 | 0.21 | 0.05 |
|
5yr CAGR Net Profit
|
n/a | 96.29 % | n/a |
|
5yr Average Return on Assets
|
15.14 % | 0.72 % | 20.09 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
34.04 % | 60.39 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
27.73 % | 21.61 % | -6.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Balgopal Commercial
|
Sicagen India
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|